A5026927905- Hepatitis C virus research
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
- HIV, Drug Use, Sexual Risk
- Hepatitis Viruses Studies and Epidemiology
- Pharmaceutical Economics and Policy
- Biosimilars and Bioanalytical Methods
- Genetics, Bioinformatics, and Biomedical Research
- Artificial Intelligence in Healthcare
- Systemic Lupus Erythematosus Research
- Diabetes Management and Education
- Diabetes Management and Research
- HIV/AIDS Research and Interventions
- Liver Disease and Transplantation
- HIV/AIDS Impact and Responses
American Foundation for AIDS Research
2024
Asia Foundation
2017-2022
All India Institute of Medical Sciences Rishikesh
2022
All India Institute of Medical Sciences Raipur
2022
Seven years after the introduction of direct-acting antivirals (DAAs) for treatment hepatitis C, high prices remain a barrier programs worldwide. This study seeks to describe current originator DAAs in 50 countries and evaluate relationship between GDP per capita.Data on sofosbuvir, daclatasvir, sofosbuvir/ledipasvir, sofosbuvir/velpatasvir, glecaprevir/pibrentasvir were collected from national databases countries. Cost-based generic estimated using an established algorithm, which accounts...
Innovation contests are a novel approach to elicit good ideas and innovative practices in various areas of public health. There remains limited published literature on approaches deliver hepatitis testing. The purpose this innovation contest was identify examples different B C support countries their scale-up testing supplement development formal recommendations service delivery the 2017 World Health Organization guidelines.This involved four steps: 1) establishment multisectoral steering...
Abstract Background Prevalence of hepatitis C virus (HCV) infection among people who inject drugs in the state Manipur, India, is 43%; however, access to care poor. We piloted a Community-led and comprehensive model that included same-day HCV treatment at drug centres. Methods Screening was conducted through venipuncture samples collected by community peer PWID, using antibody (HCV Ab) rapid screening B (HBV) surface antigen (HBsAg) diagnostic tests. Reactive Ab were tested for RNA near...
The Asia-Pacific region bears a high burden of hepatitis C virus (HCV) infections and the largest number global deaths. Populations most at risk infection disease progression include people who inject drugs those living with HIV. HCV treatment options have rapidly expanded in past few years through development direct-acting antiviral (DAA) medicines, which can cure over 95% cases, but are prohibitively expensive. While price is major barrier to access, voluntary licensing has resulted...
Abstract Background Prevalence of hepatitis C virus (HCV) infection among people who inject drugs in the state Manipur, India, is 43%; however, access to care poor. We piloted a Community-led and comprehensive model that included same-day HCV treatment at drug centres. Methods Screening was conducted using antibody (HCV Ab) B (HBV) surface antigen (HBsAg) rapid diagnostic tests. Positive Ab samples were tested point-of-care RNA. Eligible RNA-positive participants treated on same day...
Data are lacking or outdated on burden of HIV, viral hepatitis infection, and sexually transmitted infections such as syphilis among people deprived liberty in the Asia-Pacific region. We aimed to evaluate proportion B (HBV), C (HCV), infections, factors associated with HCV, HBV, HIV infection a central male prison. A cross-sectional study was performed 1,028 from prison Bangkok, Thailand. People were screened for during 2018-2019. HBV HCV defined positive surface antigen anti-HCV antibody,...
Hepatitis C virus (HCV) prevalence is high among people living with HIV co-infected HCV, who inject drugs, men have sex and inmates in correctional settings. The barriers to eliminate HCV these key populations include diagnosis challenges, lack of awareness, discrimination stigmatization. In addition, scaling up treatment has been a challenge Asia–Pacific the national policies, targets unavailability appropriate direct-acting antivirals regimens. order achieve micro elimination within...